"Eunice Wang (@EuniceWangMD) of @RoswellPark shares some updates on a Phase II study evaluating crenolanib in patients with newly diagnosed FLT3-mutated AML. &#127909;: https://t.co/dVSlIfPMJ5 @ASCO #ASCO22 #AMLsm #LeuSM #HemOnc"

crenolanib besylate (ARO-002) - AROG

Jun 22, 2022